Condition

Bladder Carcinoma

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18

Recruiting6

Common interventions25

Lead sponsors shown13

Clinical trials

18 shown

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasNCT07285044 · 2025-12-18

The Vanguard Study: Testing a New Way to Screen for CancerNCT06995898 · 2025-06-18

PET-imaging of Two Vartumabs in Patients With Solid TumorsNCT06645808 · 2024-12-10

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersNCT05519878 · 2022-11-29

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationNCT05059444 · 2021-09-07

Patient-Derived Xenografts to Reduce Cancer Health DisparitiesNCT04410302 · 2019-11-12

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersNCT07118176 · 2025-08-01

ACTIVE_NOT_RECRUITING

Vaccine Response With NT-I7NCT04054752 · 2023-05-30

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision TherapeuticsNCT05819827 · 2023-04-19

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid TumoursNCT05363605 · 2022-04-20

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceNCT06789224 · 2022-02-15

The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major SurgeryNCT03064308 · 2017-06-26

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyNCT02432963 · 2016-06-14

ACTIVE_NOT_RECRUITING

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17

ACTIVE_NOT_RECRUITING

PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare ProvidersNCT02408406 · 2015-07-07

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesNCT02457650 · 2015-04-01

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)NCT00753415 · 2008-08-01

Cone Beam CT Scanning in Lung and Bladder Cancer.NCT00469066 · 2007-05-01

Common interventions

Leading sponsors

City of Hope Medical Center 3 National Cancer Institute (NCI) 3 Mayo Clinic 2 AHS Cancer Control Alberta 1 Fusion Pharmaceuticals Inc. 1 Guardant Health, Inc. 1 Jonsson Comprehensive Cancer Center 1 Lindis Bloodcare GmbH 1 Merck Sharp & Dohme LLC 1 Shenzhen Second People's Hospital 1 University of California, Davis 1 University of Nottingham 1 Var2 Pharmaceuticals 1

Trial status mix

RECRUITING6

COMPLETED5

ACTIVE_NOT_RECRUITING3

TERMINATED2

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE16

NA5

PHASE23

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.